Bexlutry

1 entry tagged Bexlutry. All writing.

SEPTEMBER 17, 2026 What Radioligand Therapy Is, and Why a Second Lutathera Matters On September 14 the FDA approved Bexlutry, Curium's copy of Novartis's Lutathera — the first "radioligand equivalent" ever cleared. The question underneath the headline: what is a radioligand therapy, what does the evidence say it does for neuroendocrine tumours, and why did it take a Delaware courtroom to get a second one to market? With numbers, and the companies.

Medical disclaimer. Everything on this site is general information for education only. It is not medical, nutritional or health advice, and it is not a substitute for advice from a licensed physician, pharmacist, dietitian or other qualified health professional who knows you. The author is not a licensed health professional and writes under a pen name; no entry has been reviewed by a doctor or anyone else with a medical licence. Reading this site, or writing to it, creates no doctor–patient or other professional relationship. Do not start, stop or change any medication, supplement, diet or treatment because of something read here — talk to your clinician first. If you think you may have a medical emergency, call your doctor or your local emergency number (911 in the United States) now. Read the full disclaimer →